Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Transenterix Inc (TRXC)

Transenterix Inc (TRXC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 648,208
  • Shares Outstanding, K 142,777
  • Annual Sales, $ 8,530 K
  • Annual Income, $ -154,200 K
  • 60-Month Beta 1.95
  • Price/Sales 67.21
  • Price/Cash Flow 3.29
  • Price/Book 6.55
Trade TRXC with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.57
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 03/11/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate -0.11
  • Number of Estimates 1
  • High Estimate -0.11
  • Low Estimate -0.11
  • Prior Year -0.83
  • Growth Rate Est. (year over year) +86.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.10 +31.61%
on 02/05/21
6.95 -41.29%
on 02/10/21
+0.89 (+27.90%)
since 02/04/21
3-Month
0.49 +730.96%
on 12/15/20
6.95 -41.29%
on 02/10/21
+3.57 (+705.37%)
since 12/04/20
52-Week
0.28 +1,357.14%
on 03/19/20
6.95 -41.29%
on 02/10/21
+2.94 (+257.89%)
since 03/04/20

Most Recent Stories

More News
Asensus Surgical Announces Finalization of Name and Ticker Symbol Change

Asensus Surgical , Inc. (formerly TransEnterix, Inc.) (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
ASXC : 0.2380 (+1.71%)
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021

Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
Asensus Surgical Announces FDA Clearance in General Surgery

Asensus Surgical , Inc. (formerly TransEnterix, Inc.) (NYSE American: TRXC) , a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
Asensus Surgical to Present at the H.C. Wainwright Virtual Global Life Sciences Conference

Asensus Surgical , Inc. (NYSE American: TRXC) (formerly TransEnterix, Inc.), a medical device company that is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided...

TRXC : 4.08 (-10.13%)
TransEnterix Announces Name Change to Asensus Surgical and Introduces a New Category of Surgery, Performance-Guided Surgery

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will...

TRXC : 4.08 (-10.13%)
TransEnterix Announces New Training Center in EU

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the Company...

TRXC : 4.08 (-10.13%)
Global Cardiovascular Devices Market Now Project to Exceed $71 Billion By 2027

Palm Beach, FL – February 11, 2021 – Cardiovascular devices are the medical devices which are used to diagnosis and treat the heart diseases and other heart-related problems.  These devices play essential...

PAVM : 2.52 (-7.69%)
BSGM : 0.7700 (+5.48%)
MDT : 86.92 (unch)
BSX : 68.62 (unch)
TRXC : 4.08 (-10.13%)
TransEnterix to Host Virtual Investor Day on February 23, 2021

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced that it will...

TRXC : 4.08 (-10.13%)
TransEnterix Announces Closing of $79.6 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced the closing...

TRXC : 4.08 (-10.13%)
TransEnterix Increases Previously Announced Bought Deal Offering of Common Stock to $69.25 Million

TransEnterix, Inc. (NYSE American: TRXC) (“TransEnterix” or the “Company”), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive...

TRXC : 4.08 (-10.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

TransEnterix Inc. designs, develops and manufactures medical-devices. It offers SPIDER(R) Surgical System, a laparoscopic surgical platform that allows intra-abdominal triangulation procedures to be performed with articulating instruments through a single site. The company is primarily focused on the...

See More

Key Turning Points

3rd Resistance Point 5.84
2nd Resistance Point 5.31
1st Resistance Point 4.69
Last Price 4.08
1st Support Level 3.54
2nd Support Level 3.01
3rd Support Level 2.39

See More

52-Week High 6.95
Fibonacci 61.8% 4.40
Last Price 4.08
Fibonacci 50% 3.62
Fibonacci 38.2% 2.83
52-Week Low 0.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar